Literature DB >> 19958931

Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism.

Aliya Heyliger1, Vin Tangpricha, Collin Weber, Jyotirmay Sharma.   

Abstract

BACKGROUND: Primary hyperparathyroidism (PHPT) is associated with an increased risk of cardiovascular disease, including hypertension. The purpose of this study was to determine the effect of parathyroidectomy on systolic and diastolic blood pressures (BP) in hypertensive patients with PHPT.
METHODS: A retrospective review of medical records was performed in 368 patients undergoing parathyroidectomy and 96 patients undergoing thyroidectomy by a single surgeon. We evaluated changes in serum calcium, parathyroid hormone (PTH), and BP before and 6 months after surgery.
RESULTS: In patients undergoing parathyroidectomy with hypertension (n = 147), a significant decrease in both systolic and diastolic BP was observed; systolic BP decreased from 152.5 +/- 10.5 to 140.3 +/- 16.2 mmHg (P < .001) and diastolic BP decreased from 94.5 +/- 6.8 to 81.7 +/- 10.3 mmHg (P < .001). In these patients, PTH decreased from 136 +/- 186 to 58.7 +/- 44.3 pg/mL (P < .001) and serum calcium decreased from 11.1 +/- 0.6 to 9.5 +/- 0.7 mg/dL (P < .001). In patients undergoing parathyroidectomy without hypertension (n = 145) and thyroidectomy alone (n = 96), no significant change in systolic or diastolic BP was observed.
CONCLUSION: Parathyroidectomy in hypertensive patients seems to reduce both systolic and diastolic BP . The mechanisms responsible for this effect are unknown and deserve further study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19958931      PMCID: PMC2845911          DOI: 10.1016/j.surg.2009.09.024

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

1.  Effects of acute hypercalcaemia on blood pressure in subjects with and without parathyroid hormone secretion.

Authors:  E Kamycheva; R Jorde; E Haug; G Sager; J Sundsfjord
Journal:  Acta Physiol Scand       Date:  2005-06

2.  PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells.

Authors:  G Mazzocchi; F Aragona; L K Malendowicz; G G Nussdorfer
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-02       Impact factor: 4.310

3.  Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia.

Authors:  I L Nilsson; J Rastad; K Johansson; L Lind
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

4.  Asymptomatic primary hyperparathyroidism. 10-year prospective study.

Authors:  D A Scholz; D C Purnell
Journal:  Mayo Clin Proc       Date:  1981-08       Impact factor: 7.616

5.  Augmentation of central arterial pressure in mild primary hyperparathyroidism.

Authors:  J C Smith; M D Page; R John; M H Wheeler; J R Cockcroft; M F Scanlon; J S Davies
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Sympathetic system function and vascular reactivity in hypercalcemic patients.

Authors:  N D Vlachakis; R Frederics; M Valasquez; N Alexander; F Singer; R F Maronde
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

7.  A case-comparison study of hypertension and hyperparathyroidism.

Authors:  J C Nainby-Luxmoore; H G Langford; N C Nelson; R L Watson; T Y Barnes
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

8.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

9.  Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells.

Authors:  Vlado Perkovic; Timothy D Hewitson; Kristen J Kelynack; Marina Martic; Melanie G Tait; Gavin J Becker
Journal:  Kidney Blood Press Res       Date:  2003       Impact factor: 2.687

10.  Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak.

Authors:  D A McCarron; P A Pingree; R J Rubin; S M Gaucher; M Molitch; S Krutzik
Journal:  Hypertension       Date:  1980 Mar-Apr       Impact factor: 10.190

View more
  25 in total

1.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.

Authors:  A Concistrè; A Grillo; G La Torre; R Carretta; B Fabris; L Petramala; C Marinelli; A Rebellato; F Fallo; C Letizia
Journal:  Endocrine       Date:  2017-07-12       Impact factor: 3.633

2.  Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.

Authors:  Songcang Chen; Christopher S Law; Christopher L Grigsby; Keith Olsen; Ting-Ting Hong; Yan Zhang; Yerem Yeghiazarians; David G Gardner
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

Review 3.  The Endocrine Role of Bone in Cardiometabolic Health.

Authors:  Rosemary DeLuccia; May Cheung; Rohit Ramadoss; Abeer Aljahdali; Deeptha Sukumar
Journal:  Curr Nutr Rep       Date:  2019-09

4.  Differential Effect of Renal Cortical and Medullary Interstitial Fluid Calcium on Blood Pressure Regulation in Salt-Sensitive Hypertension.

Authors:  Mildred A Pointer; Shaleka Eley; Lauren Anderson; Brittany Waters; Brittany Royall; Sheena Nichols; Candace Wells
Journal:  Am J Hypertens       Date:  2014-12-31       Impact factor: 2.689

Review 5.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

6.  Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.

Authors:  Jyotirmay Sharma; Dina S Itum; Lewis Moss; C Li; Christine Chun-Li; Collin Weber
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

7.  The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis.

Authors:  Maryam Yavari; Awat Feizi; Fahimeh Haghighatdoost; Azin Ghaffari; Hassan Rezvanian
Journal:  Endocrine       Date:  2020-10-15       Impact factor: 3.633

Review 8.  Primary hyperparathyroidism and hypertension.

Authors:  Sarah B Fisher; Nancy D Perrier
Journal:  Gland Surg       Date:  2020-02

9.  Association of calcium concentration with pulse pressure in older women: data from a large population-based multicentric study.

Authors:  L Mateus-Hamdan; O Beauchet; Y Rolland; A-M Schott; C Annweiler
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

Review 10.  Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.

Authors:  Shyamal Palit; Jessica Kendrick
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.